Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP525908.RAVpvOlDNtY2e0znW8HCJF8Qrz9gyLGZSWxHgr_Wmz_dE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP525908.RAVpvOlDNtY2e0znW8HCJF8Qrz9gyLGZSWxHgr_Wmz_dE130_assertion type Assertion NP525908.RAVpvOlDNtY2e0znW8HCJF8Qrz9gyLGZSWxHgr_Wmz_dE130_head.
- NP525908.RAVpvOlDNtY2e0znW8HCJF8Qrz9gyLGZSWxHgr_Wmz_dE130_assertion description "[In breast cancer the c-kit gene mutation rates were 3.44% (02/58) in exon 8, 5.17% (3/58) in exon 9, 5.17% (3/58) in exon 11, 3.44% (2/580 in exon 13, 3.44% (2/58) in exon 15 and 5.17% (3/58) in exon 17, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP525908.RAVpvOlDNtY2e0znW8HCJF8Qrz9gyLGZSWxHgr_Wmz_dE130_provenance.
- NP525908.RAVpvOlDNtY2e0znW8HCJF8Qrz9gyLGZSWxHgr_Wmz_dE130_assertion evidence source_evidence_literature NP525908.RAVpvOlDNtY2e0znW8HCJF8Qrz9gyLGZSWxHgr_Wmz_dE130_provenance.
- NP525908.RAVpvOlDNtY2e0znW8HCJF8Qrz9gyLGZSWxHgr_Wmz_dE130_assertion SIO_000772 23582602 NP525908.RAVpvOlDNtY2e0znW8HCJF8Qrz9gyLGZSWxHgr_Wmz_dE130_provenance.
- NP525908.RAVpvOlDNtY2e0znW8HCJF8Qrz9gyLGZSWxHgr_Wmz_dE130_assertion wasDerivedFrom befree-20150227 NP525908.RAVpvOlDNtY2e0znW8HCJF8Qrz9gyLGZSWxHgr_Wmz_dE130_provenance.
- NP525908.RAVpvOlDNtY2e0znW8HCJF8Qrz9gyLGZSWxHgr_Wmz_dE130_assertion wasGeneratedBy ECO_0000203 NP525908.RAVpvOlDNtY2e0znW8HCJF8Qrz9gyLGZSWxHgr_Wmz_dE130_provenance.